Skip to main content
Atrás
EW logo

Edwards Lifesciences Corporation

Calidad de datos: 100%
EW
NYSE Healthcare Medical - Devices
$81.69
▼ $0.33 (-0.40%)
Cap. Mercado: 47.45B
Rango del Día
$80.60 $82.33
Rango de 52 Semanas
$65.94 $87.89
Volumen
3,018,814
Promedio 50D / 200D
$82.43 / $80.42
Cierre Anterior
$82.02

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E 44.2 0.4
P/B 4.6 2.9
ROE % 10.6 3.9
Net Margin % 17.7 3.8
Rev Growth 5Y % 3.8 10.0
D/E 0.1 0.2

Precio Objetivo de Analistas

Hold
$96.38 +18.0%
Low: $87.00 High: $110.00
P/E Futuro
27.6
EPS Futuro
$2.97
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
6.7 B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 $4.56
$4.47 – $4.63
 9.7 B 2
FY2029 $4.20
$4.12 – $4.27
 8.9 B 2
FY2028 $3.73
$3.54 – $3.92
 8.1 B 4

Puntos Clave

Revenue grew 3.77% annually over 5 years — modest growth
Earnings declined -74.28% over the past year
ROE of 10.56% — decent returns on equity
Net margin of 17.69% shows strong profitability
Debt/Equity of 0.07 — conservative balance sheet
Generating 1.34B in free cash flow

Crecimiento

Revenue Growth (5Y)
3.77%
Revenue (1Y)11.55%
Earnings (1Y)-74.28%
FCF Growth (3Y)45.63%

Calidad

Return on Equity
10.56%
ROIC11.11%
Net Margin17.69%
Op. Margin26.97%

Seguridad

Debt / Equity
0.07
Current Ratio3.72
Interest Coverage0.00

Valoración

P/E Ratio
44.20
P/B Ratio4.59
EV/EBITDA27.63
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.55% Revenue Growth (3Y) 10.05%
Earnings Growth (1Y) -74.28% Earnings Growth (3Y) -12.51%
Revenue Growth (5Y) 3.77% Earnings Growth (5Y) -8.07%
Profitability
Revenue (TTM) 6.07B Net Income (TTM) 1.07B
ROE 10.56% ROA 7.84%
Gross Margin 78.13% Operating Margin 26.97%
Net Margin 17.69% Free Cash Flow (TTM) 1.34B
ROIC 11.11% FCF Growth (3Y) 45.63%
Safety
Debt / Equity 0.07 Current Ratio 3.72
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio 44.20 P/B Ratio 4.59
P/S Ratio 7.82 PEG Ratio -0.63
EV/EBITDA 27.63 Dividend Yield 0.00%
Market Cap 47.45B Enterprise Value 45.21B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6.07B 5.44B 5.01B 5.38B 5.23B
Net Income 1.07B 4.17B 1.40B 1.52B 1.50B
EPS (Diluted) 1.83 6.97 2.30 2.44 2.38
Gross Profit 4.74B 4.32B 3.97B 4.22B 4.01B
Operating Income 1.64B 1.38B 1.43B 1.70B 1.61B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13.70B 13.06B 9.36B 8.29B 8.50B
Total Liabilities 3.36B 2.99B 2.64B 2.49B 2.67B
Shareholders' Equity 10.34B 10.00B 6.65B 5.81B 5.84B
Total Debt 705.40M 700.00M 685.10M 691.30M 690.30M
Cash & Equivalents 2.94B 3.05B 1.13B 769.00M 862.80M
Current Assets 6.74B 6.29B 4.04B 3.10B 3.18B
Current Liabilities 1.81B 1.51B 1.20B 1.02B 1.03B